SKI Market

A+| A| A-|

Indian Indices

Sensex

75,237.99 -160.73
( -0.21%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kotak Mahindra Bank Ltd

Industry : Banks - Private Sector

BSE Code

ISIN Demat

Book Value()

500247

INE237A01036

135.9262685

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KOTAKBANK

27.51

385226.59

EPS(TTM)

Face Value()

Div & Yield %

14.08

0.17

Back

Marksans Pharma consolidated net profit rises 8.26% in the December 2025 quarter

Feb 05,2026

Net profit of Marksans Pharma rose 8.26% to Rs 113.20 crore in the quarter ended December 2025 as against Rs 104.56 crore during the previous quarter ended December 2024. Sales rose 10.64% to Rs 754.43 crore in the quarter ended December 2025 as against Rs 681.85 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	754.43	681.85	11
OPM %	21.31	20.35	-
PBDT	174.95	163.95	7
PBT	150.62	143.26	5
NP	113.20	104.56	8

75,237.99 -160.73 ( -0.21%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

61,141.50 -1,512.55 (-2.41%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)